Financial statements Apteka Eskulap
Balance sheet data of APTEKA ESKULAP
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 061 264,66 | 1 190 266,97 | 1 556 111,28 | 1 527 808,54 | 1 749 492,74 | 2 318 704,88 |
| A. Fixed assets | 203 461,46 | 195 032,87 | 181 486,66 | 167 481,63 | 164 167,83 | 157 370,15 |
| B. Current assets | 857 803,20 | 995 234,10 | 1 374 624,62 | 1 360 326,91 | 1 585 324,91 | 2 161 334,73 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 061 264,66 | 1 190 266,97 | 1 556 111,28 | 1 527 808,54 | 1 749 492,74 | 2 318 704,88 |
| A. Equity | 197 640,38 | 309 064,67 | 517 881,26 | 514 718,09 | 784 464,63 | 1 099 669,98 |
| B. Liabilities and provisions for liabilities | 863 624,28 | 881 202,30 | 1 038 230,02 | 1 013 090,45 | 965 028,11 | 1 219 034,90 |
| I. Long-term liabilities | 0,00 | - | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 845 308,69 | - | 1 003 713,45 | 991 760,15 | 918 205,21 | 1 182 354,01 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.